{
    "hands_on_practices": [
        {
            "introduction": "Understanding the normal endometrial cycle is powerfully reinforced by contrasting it with pathological states. This first exercise  challenges you to quantify the stark differences between a normal secretory endometrium and an anovulatory endometrium exposed to unopposed estrogen. By calculating the proliferation index ($Ki-67$) and steroid receptor H-scores, you will translate foundational endocrine principles into the concrete data used in clinical pathology.",
            "id": "4432628",
            "problem": "A research histopathology laboratory quantifies steroid receptor expression and proliferation in endometrium by immunohistochemistry using standard approaches validated for gynecologic tissues. The endometrium is partitioned into the functionalis and basalis compartments, and fractional areas are estimated by point-counting morphometry. For proliferation, the laboratory reports the Ki-67 index as the compartment-specific fraction of nuclei that show Ki-67 immunoreactivity. For steroid receptors, the laboratory uses the standard histochemical score (H-score), defined for each compartment as $$H = \\sum_{i=0}^{3} i \\times P_{i},$$ where $i$ denotes the ordinal intensity class ($0$, $1$, $2$, $3$), and $P_{i}$ is the percentage of cells in that compartment staining at intensity $i$. The overall tissue-level values are obtained by area-weighted averaging across functionalis and basalis compartments. The estradiol receptor (ER) to progesterone receptor (PR) ratio is defined as the ratio of the area-weighted ER H-score to the area-weighted PR H-score.\n\nTwo cohorts are analyzed:\n- Anovulatory endometrium (persistent estrogen exposure without a luteal phase).\n- Normal secretory-phase endometrium (mid-late secretory phase).\n\nUse the following immunostaining data:\n\nAnovulatory endometrium:\n- Fractional areas: functionalis $0.65$, basalis $0.35$.\n- Ki-67 positivity (fraction of nuclei positive):\n  - Functionalis: $0.45$.\n  - Basalis: $0.18$.\n- ER intensity distribution (percent cells at each intensity):\n  - Functionalis: $P_{0}=10$, $P_{1}=10$, $P_{2}=50$, $P_{3}=30$.\n  - Basalis: $P_{0}=15$, $P_{1}=20$, $P_{2}=40$, $P_{3}=25$.\n- PR intensity distribution (percent cells at each intensity):\n  - Functionalis: $P_{0}=20$, $P_{1}=20$, $P_{2}=40$, $P_{3}=20$.\n  - Basalis: $P_{0}=35$, $P_{1}=15$, $P_{2}=35$, $P_{3}=15$.\n\nNormal secretory-phase endometrium:\n- Fractional areas: functionalis $0.75$, basalis $0.25$.\n- Ki-67 positivity (fraction of nuclei positive):\n  - Functionalis: $0.06$.\n  - Basalis: $0.12$.\n- ER intensity distribution (percent cells at each intensity):\n  - Functionalis: $P_{0}=50$, $P_{1}=30$, $P_{2}=18$, $P_{3}=2$.\n  - Basalis: $P_{0}=30$, $P_{1}=30$, $P_{2}=30$, $P_{3}=10$.\n- PR intensity distribution (percent cells at each intensity):\n  - Functionalis: $P_{0}=20$, $P_{1}=35$, $P_{2}=35$, $P_{3}=10$.\n  - Basalis: $P_{0}=25$, $P_{1}=35$, $P_{2}=30$, $P_{3}=10$.\n\nStarting from the definitions above and biological first principles that proliferation in endometrium is driven by estradiol and restrained by progesterone signaling, and that the functionalis compartment is the hormonally responsive layer, derive the area-weighted Ki-67 indices for each cohort and the ER/PR ratios for each cohort. Express Ki-67 indices as decimal fractions (no percentage sign), ER/PR ratios as dimensionless decimals. Round each of the four required outputs to four significant figures. Report your final answers in the order: anovulatory Ki-67, secretory Ki-67, anovulatory ER/PR, secretory ER/PR.",
            "solution": "The problem requires calculating the area-weighted Ki-67 index and the ER/PR ratio for two endometrial cohorts: anovulatory and normal secretory.\n\nThe area-weighted value for any index $X$ is calculated as $X_{total} = A_F \\cdot X_F + A_B \\cdot X_B$, where $A_F, A_B$ are the fractional areas and $X_F, X_B$ are the index values in the functionalis and basalis compartments, respectively.\n\nThe Histochemical Score (H-score) is calculated as $H = \\sum_{i=1}^{3} i \\times P_{i}$.\n\n**1. Calculations for Anovulatory Endometrium**\n- Areas: $A_F = 0.65$, $A_B = 0.35$.\n- Ki-67 indices: $Ki67_F = 0.45$, $Ki67_B = 0.18$.\n\n**a) Area-Weighted Ki-67 Index:**\n$$Ki67_{anov} = (0.65)(0.45) + (0.35)(0.18) = 0.2925 + 0.063 = 0.3555$$\n\n**b) ER/PR Ratio:**\n- ER H-score (Functionalis): $H_{ER,F} = (1 \\cdot 10) + (2 \\cdot 50) + (3 \\cdot 30) = 200$.\n- ER H-score (Basalis): $H_{ER,B} = (1 \\cdot 20) + (2 \\cdot 40) + (3 \\cdot 25) = 175$.\n- Area-weighted ER H-score: $H_{ER,anov} = (0.65)(200) + (0.35)(175) = 130 + 61.25 = 191.25$.\n\n- PR H-score (Functionalis): $H_{PR,F} = (1 \\cdot 20) + (2 \\cdot 40) + (3 \\cdot 20) = 160$.\n- PR H-score (Basalis): $H_{PR,B} = (1 \\cdot 15) + (2 \\cdot 35) + (3 \\cdot 15) = 130$.\n- Area-weighted PR H-score: $H_{PR,anov} = (0.65)(160) + (0.35)(130) = 104 + 45.5 = 149.5$.\n\n- ER/PR Ratio:\n$$R_{anov} = \\frac{H_{ER,anov}}{H_{PR,anov}} = \\frac{191.25}{149.5} \\approx 1.279264 \\rightarrow 1.279$$\n\n**2. Calculations for Normal Secretory-Phase Endometrium**\n- Areas: $A_F = 0.75$, $A_B = 0.25$.\n- Ki-67 indices: $Ki67_F = 0.06$, $Ki67_B = 0.12$.\n\n**a) Area-Weighted Ki-67 Index:**\n$$Ki67_{sec} = (0.75)(0.06) + (0.25)(0.12) = 0.045 + 0.030 = 0.07500$$\n\n**b) ER/PR Ratio:**\n- ER H-score (Functionalis): $H_{ER,F} = (1 \\cdot 30) + (2 \\cdot 18) + (3 \\cdot 2) = 72$.\n- ER H-score (Basalis): $H_{ER,B} = (1 \\cdot 30) + (2 \\cdot 30) + (3 \\cdot 10) = 120$.\n- Area-weighted ER H-score: $H_{ER,sec} = (0.75)(72) + (0.25)(120) = 54 + 30 = 84$.\n\n- PR H-score (Functionalis): $H_{PR,F} = (1 \\cdot 35) + (2 \\cdot 35) + (3 \\cdot 10) = 135$.\n- PR H-score (Basalis): $H_{PR,B} = (1 \\cdot 35) + (2 \\cdot 30) + (3 \\cdot 10) = 125$.\n- Area-weighted PR H-score: $H_{PR,sec} = (0.75)(135) + (0.25)(125) = 101.25 + 31.25 = 132.5$.\n\n- ER/PR Ratio:\n$$R_{sec} = \\frac{H_{ER,sec}}{H_{PR,sec}} = \\frac{84}{132.5} \\approx 0.633962 \\rightarrow 0.6340$$\n\n**Final Results:**\nThe four results in the specified order are:\n1.  Anovulatory Ki-67: $0.3555$\n2.  Secretory Ki-67: $0.07500$\n3.  Anovulatory ER/PR: $1.279$\n4.  Secretory ER/PR: $0.6340$",
            "answer": "$$\n\\boxed{\n\\begin{pmatrix}\n0.3555 & 0.07500 & 1.279 & 0.6340\n\\end{pmatrix}\n}\n$$"
        },
        {
            "introduction": "Successful implantation depends on the development of a highly vascularized receptive endometrium. This practice  focuses on quantifying the dramatic remodeling of spiral arteries, a hallmark of the secretory phase. Using histomorphometric data, you will calculate a functional \"Perfusion Capacity Index,\" providing a tangible link between microscopic vascular anatomy and the tissue's readiness for pregnancy.",
            "id": "4432640",
            "problem": "A standardized histomorphometric assessment is performed on human endometrium to quantify spiral artery remodeling across the menstrual cycle. Remodeling is driven by fluctuations in estradiol and progesterone, producing phase-specific changes in vessel number and caliber. Spiral artery density is defined as the number of spiral artery lumens per unit tissue area, and cross-sectional lumen area is approximated by a circle of measured diameter. Four non-overlapping histology fields of area $1$ $\\mathrm{mm}^{2}$ each are sampled in the Early Proliferative Phase (EPP) and in the Mid-Secretory Phase (MSP). For each field, all spiral artery luminal diameters are measured in micrometers. The dataset is:\n\n- Early Proliferative Phase (EPP), each field has area $1$ $\\mathrm{mm}^{2}$:\n  - Field $F_{1}$: $n=5$ lumens with diameters $48, 52, 55, 50, 60$ $\\mathrm{\\mu m}$.\n  - Field $F_{2}$: $n=4$ lumens with diameters $45, 47, 50, 53$ $\\mathrm{\\mu m}$.\n  - Field $F_{3}$: $n=6$ lumens with diameters $49, 54, 51, 57, 65, 59$ $\\mathrm{\\mu m}$.\n  - Field $F_{4}$: $n=5$ lumens with diameters $46, 48, 52, 58, 55$ $\\mathrm{\\mu m}$.\n\n- Mid-Secretory Phase (MSP), each field has area $1$ $\\mathrm{mm}^{2}$:\n  - Field $F_{1}$: $n=4$ lumens with diameters $90, 100, 95, 110$ $\\mathrm{\\mu m}$.\n  - Field $F_{2}$: $n=5$ lumens with diameters $85, 92, 88, 94, 90$ $\\mathrm{\\mu m}$.\n  - Field $F_{3}$: $n=3$ lumens with diameters $120, 130, 125$ $\\mathrm{\\mu m}$.\n  - Field $F_{4}$: $n=4$ lumens with diameters $98, 102, 105, 95$ $\\mathrm{\\mu m}$.\n\nAssume each lumen cross-section is circular with diameter $d$ and area $A=\\pi \\left(\\frac{d}{2}\\right)^{2}$, where $d$ is converted to millimeters by $d_{\\mathrm{mm}}=d_{\\mathrm{\\mu m}}\\times 10^{-3}$. Define the Perfusion Capacity Index (PCI) for a phase as the total luminal area of all spiral arteries across the $4$ fields divided by the total sampled tissue area. Using only the above definitions and data, compute the fold-change $r=\\frac{\\mathrm{PCI}_{\\mathrm{MSP}}}{\\mathrm{PCI}_{\\mathrm{EPP}}}$. Express $r$ as a unitless ratio, and round your answer to four significant figures.",
            "solution": "The goal is to calculate the fold-change $r = \\frac{\\mathrm{PCI}_{\\mathrm{MSP}}}{\\mathrm{PCI}_{\\mathrm{EPP}}}$.\n\nThe Perfusion Capacity Index (PCI) is defined as:\n$$ \\text{PCI} = \\frac{\\text{Total Luminal Area}}{\\text{Total Sampled Tissue Area}} $$\nThe total sampled tissue area is $4 \\times 1 \\ \\mathrm{mm}^2 = 4 \\ \\mathrm{mm}^2$ for both phases.\nThe area of a single lumen with diameter $d$ (in mm) is $A_L = \\frac{\\pi}{4}d^2$. The total luminal area is the sum of all individual lumen areas.\n$$ \\text{Total Luminal Area} = \\sum_{i} \\frac{\\pi}{4} (d_{i, [\\mu m]} \\times 10^{-3})^2 = \\frac{\\pi}{4} \\times 10^{-6} \\sum_{i} (d_{i, [\\mu m]})^2 $$\nTherefore, the PCI for a phase is:\n$$ \\text{PCI} = \\frac{\\frac{\\pi}{4} \\times 10^{-6} \\sum d^2}{4} = \\frac{\\pi \\times 10^{-6}}{16} \\sum d^2 $$\nThe ratio $r$ simplifies because the constant factors cancel out:\n$$ r = \\frac{\\mathrm{PCI}_{\\mathrm{MSP}}}{\\mathrm{PCI}_{\\mathrm{EPP}}} = \\frac{\\frac{\\pi \\times 10^{-6}}{16} \\sum d_{\\mathrm{MSP}}^2}{\\frac{\\pi \\times 10^{-6}}{16} \\sum d_{\\mathrm{EPP}}^2} = \\frac{\\sum d_{\\mathrm{MSP}}^2}{\\sum d_{\\mathrm{EPP}}^2} $$\nWe need to calculate the sum of the squares of the diameters (in $\\mu m$) for each phase.\n\n**1. Early Proliferative Phase (EPP):**\n- The sum of squares of all diameters ($\\sum d_{\\mathrm{EPP}}^2$):\n$48^2+52^2+55^2+50^2+60^2 = 14133$\n$45^2+47^2+50^2+53^2 = 9543$\n$49^2+54^2+51^2+57^2+65^2+59^2 = 18873$\n$46^2+48^2+52^2+58^2+55^2 = 13513$\n$$ \\sum d_{\\mathrm{EPP}}^2 = 14133 + 9543 + 18873 + 13513 = 56062 $$\n\n**2. Mid-Secretory Phase (MSP):**\n- The sum of squares of all diameters ($\\sum d_{\\mathrm{MSP}}^2$):\n$90^2+100^2+95^2+110^2 = 39225$\n$85^2+92^2+88^2+94^2+90^2 = 40369$\n$120^2+130^2+125^2 = 46925$\n$98^2+102^2+105^2+95^2 = 40058$\n$$ \\sum d_{\\mathrm{MSP}}^2 = 39225 + 40369 + 46925 + 40058 = 166577 $$\n\n**3. Fold-Change Ratio (r):**\n$$ r = \\frac{166577}{56062} \\approx 2.971281... $$\nRounding to four significant figures, the result is $2.971$.",
            "answer": "$$\n\\boxed{2.971}\n$$"
        },
        {
            "introduction": "Our final challenge transitions from calculating specific metrics to the integrative reasoning required for histological diagnosis. This exercise  asks you to 'date' endometrial biopsies by synthesizing quantitative data on gland tortuosity, secretions, and stromal edema. Applying your knowledge of the secretory phase's temporal evolution, you will identify which samples fall within the critical 'window of implantation,' a skill central to reproductive pathology.",
            "id": "4432691",
            "problem": "A research team is validating a morphometric approach to classify endometrial biopsies into the mid-secretory receptive phase using quantitative histology. They base their approach on foundational physiology: after ovulation at the Luteinizing Hormone (LH) surge ($LH+0$), progesterone acts on estrogen-primed endometrium to induce secretory transformation. This transformation progresses over days, producing characteristic changes in gland architecture, epithelial secretions, and stromal hydration that reach a reproducible pattern during the window of implantation (mid-secretory phase, approximately $LH+7$ to $LH+10$). The team measures three features on digitized sections using stereology and image analysis:\n\n- Gland tortuosity index $t$ (mean ratio of gland path length to straight-line distance, unitless).\n- Secretion prevalence $s$ (percent of glands exhibiting apical/luminal secretions, $\\%$).\n- Stromal edema fraction $e$ (fraction of stromal area occupied by optically clear interstitial space, unitless in $[0,1]$).\n\nYou are given five anonymized biopsies, each obtained from a different patient during a clinically ovulatory cycle. For each biopsy, the measured values are:\n\n- $B_1$: $t=1.4$, $s=20\\%$, $e=0.54$.\n- $B_2$: $t=2.6$, $s=62\\%$, $e=0.39$.\n- $B_3$: $t=3.0$, $s=78\\%$, $e=0.19$.\n- $B_4$: $t=1.9$, $s=36\\%$, $e=0.47$.\n- $B_5$: $t=2.3$, $s=68\\%$, $e=0.34$.\n\nUsing only first-principles reasoning from the endocrine regulation of secretory transformation and the well-established cyclic histology of the endometrium (without invoking any pre-specified scoring formula), determine which biopsies are most consistent with the mid-secretory receptive endometrium (approximately $LH+7$ to $LH+10$). Choose the best option.\n\nA. $B_2$ only\n\nB. $B_2$ and $B_5$\n\nC. $B_3$ and $B_5$\n\nD. $B_2$, $B_3$, and $B_5$\n\nE. $B_1$ and $B_4$",
            "solution": "The problem requires identifying which biopsy samples are most consistent with the mid-secretory receptive endometrium (approximately LH+7 to LH+10) based on three quantitative histological features: gland tortuosity ($t$), secretion prevalence ($s$), and stromal edema ($e$). We apply first principles of endometrial histology.\n\n**Histological Principles of the Secretory Phase:**\n1.  **Gland Tortuosity ($t$):** Glands become increasingly coiled and tortuous under progesterone stimulation. Tortuosity is low in the early secretory phase and high in the mid-to-late secretory phase. For the receptive window, we expect a **high** value.\n2.  **Secretion Prevalence ($s$):** Glandular secretions become prominent in the mid-secretory phase as glycogen is released into the lumens. For the receptive window, we expect a **high** value.\n3.  **Stromal Edema ($e$):** Stromal edema peaks around day LH+7 and then begins to decrease as the stroma undergoes predecidualization and becomes more compact in the late secretory phase. For the LH+7 to LH+10 window, we expect a **moderate to high, but likely declining,** value. A very high value is more characteristic of the early-secretory peak, and a very low value suggests the late secretory phase.\n\n**Analysis of Biopsies:**\n-   **$B_1$: ($t=1.4, s=20\\%, e=0.54$)**: Low tortuosity and secretion with peak edema suggests the **early secretory phase** (pre-receptive).\n-   **$B_2$: ($t=2.6, s=62\\%, e=0.39$)**: High tortuosity, high secretion, and moderate edema. This profile is a classic fit for the **mid-secretory/receptive phase**.\n-   **$B_3$: ($t=3.0, s=78\\%, e=0.19$)**: Very high tortuosity and secretion but very low edema. The low edema indicates stromal compaction, characteristic of the **late secretory phase** (post-receptive).\n-   **$B_4$: ($t=1.9, s=36\\%, e=0.47$)**: Moderate glandular development with high edema suggests the **early-to-mid secretory transition** (pre-receptive or just at the beginning).\n-   **$B_5$: ($t=2.3, s=68\\%, e=0.34$)**: High tortuosity, high secretion, and moderate edema. This profile is also a classic fit for the **mid-secretory/receptive phase**, very similar to $B_2$.\n\n**Conclusion:**\nBiopsies $B_2$ and $B_5$ are the only ones that exhibit the combined features of a mid-secretory receptive endometrium. Therefore, they are the correct choices. This corresponds to option B.",
            "answer": "$$\\boxed{B}$$"
        }
    ]
}